跳至主要内容
临床试验/NCT01903148
NCT01903148已完成不适用

ANEMIA MANAGEMENT IN CHRONIC KIDNEY DISEASE NOT ON DIALYSIS PATIENTS AFTER THE ERBP WORKING GROUP RECOMMENDATIONS

Fundación Senefro29 个研究点 分布在 1 个国家目标入组 455 人开始时间: 2011年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
455
试验地点
29
主要终点
% Patients Achieving Target Hemoglobin Levels

研究概览

简要总结

The purpose of this study is to evaluate the impact of the last recommendations of the European Anemia Working Group ERBP in the anemia management in the achievement of the therapeutic goal of Hb 11-12 g/dL.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults patients with anemia secondary to chronic kidney disease (CKD) not on dialysis.
  • Patients starting anemia treatment (naïve) after six months of the last recommendations of the European Anemia Working Group ERBP (January 2011).
  • Patients in treatment who changed from previous ESA treatment since January 2011 (converted patients

排除标准

  • Patients in Erythropoiesis Stimulating Agents (ESA) dose adjustment period.
  • Kidney transplant patients.

结局指标

主要结局

% Patients Achieving Target Hemoglobin Levels

时间窗: 1 day because is a crosssectional study with only a visit

% patients with Hb levels between 11-12 mg/dl

次要结局

  • Iron Treatment(1 day)
  • Patients With Hb<11(1 day)
  • Patients With Hb>12(1 day)
  • % Patients With Erythropoiesis Stimulating Agents (ESA) Therapy(1 day)
  • Hemoglobin Levels Per Type of Patients(1 day)

研究者

发起方
Fundación Senefro
申办方类型
Other
责任方
Sponsor

研究点 (29)

Loading locations...

相似试验